NDC 0173-0873 – Incruse Ellipta

Umeclidinium Bromide 62.5 ug/1 · Aerosol, Powder · Oral

Human Prescription Drug

Product NDC0173-0873

Product details

Brand name
Incruse Ellipta
Generic name
Umeclidinium
Labeler
GlaxoSmithKline LLC
Dosage form
Aerosol, Powder
Route
Oral
Marketing category
NDA · NDA205382
Marketed since
April 30, 2014
Listing expires
December 31, 2027
Pharmacologic class
Anticholinergic

Active ingredients

Uses, dosage, side effects and warnings for Incruse Ellipta →

Package NDC codes (2)

Package NDCDescriptionSince
0173-0873-061 TRAY in 1 CARTON (0173-0873-06) / 1 INHALER in 1 TRAY / 7 AEROSOL, POWDER in 1 INHALERApr 30, 2014
0173-0873-101 TRAY in 1 CARTON (0173-0873-10) / 1 INHALER in 1 TRAY / 30 AEROSOL, POWDER in 1 INHALERApr 30, 2014